Global Vaccine Adjuvants Market Size, Share, Growth Analysis, By Type(Pathogen-Based Adjuvants and Particulate Adjuvants), By Route of Administration(Intramuscular Route, and Intradermal Route) - Industry Forecast 2024-2031

Global Vaccine Adjuvants Market size was valued at USD 893.23 million in 2022 and is poised to grow from USD 1018.19 million in 2023 to USD 2902.45 million by 2031, growing at a CAGR of 13.99% during the forecast period (2024-2031).

The growing number of elderly and obese people is one of the main factors propelling the vaccine adjuvants market's growth. Growing investments in healthcare infrastructure are driving the demand for vaccination adjuvants. Additional secondary factors that will contribute to the vaccination adjuvant market's attractive growth prospects are technological innovations, improvements in adjuvants based on aluminum hydroxide, and individual disposable income. Technical obstacles resulting from the unfavorable reimbursement scenario in developing and underdeveloped nations would impede the expansion of the vaccine adjuvants market. Prolonged regulatory approval processes and strict regulatory compliance criteria would further impede the vaccine adjuvant market growth rate. The market's growth pace will be further slowed by adjuvant side effects. The high manufacturing costs of these medications will also be a barrier in the growth of the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vaccine Adjuvants Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vaccine Adjuvants Market Segmental Analysis

Global Vaccine Adjuvants market is segmented on the basis of Product Type, Route of Administration, Diseases, Application, and region. By Product Type, the market is segmented into Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, and others. By Route of Administration, the market is segmented into Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal, Others. By Diseases, the market is segmented into Cancer, Infectious Diseases, Others. By Application, the market is segmented into Research, and Commercial. The market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America as according region.

Drivers of the Global Vaccine Adjuvants Market

Because infectious diseases are becoming more common, it is expected that the global market for vaccine adjuvants would grow faster than average over the course of the forecast period. Immunization, for example, is one of the best ways to avoid infectious diseases. Globally, only COVID-19 claims more lives than tuberculosis (TB), which is still a major health risk because of drug-resistant TB strains. The World Health Organization (WHO) reports that over 1.6 million people died from tuberculosis (TB) in 2021.

Restraints in the Global Vaccine Adjuvants Market

The high toxicity and adverse effects of vaccination adjuvants are expected to impede the growth of the global vaccine adjuvants market. As per the CDC, adjuvanted vaccines have the potential to cause increased local symptoms like swelling, redness, and discomfort at the injection site, as well as increased systemic reactions including fever, body aches, and chills, as compared to non-adjuvanted vaccines. The adjuvants have a range of mild to severe side effects and can also occasionally cause adverse outcomes.

Market Trends of the Global Vaccine Adjuvants Market

The primary drivers of the global vaccine adjuvants market are the increased prevalence of allergies and infectious illnesses like cancer, HIV/AIDS, human papillomavirus (HPV), and tuberculosis. The current demand for innovative therapies for deadly diseases that are on the rise has led to the development of vaccinations with long-lasting effects on immunization. Currently undergoing clinical studies include AS01, ISCOM & ISCOMMATRIX, and AS02, which are examples of novel adjuvants developed by significant manufacturers. Governments from several countries are also advancing adjuvant technologies for human usage and vaccination programs. They are also concentrating on enhancing the healthcare system and obtaining funding for the investigation and development of new treatments.